Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent (COMPARE-II)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2014 by Maasstad Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Maasstad Hospital
ClinicalTrials.gov Identifier:
NCT01233453
First received: October 28, 2010
Last updated: January 29, 2014
Last verified: January 2014